Skip to main content
Markets
/
ABBOTINDIA · NSE
Market closedNSE | BSE
Loading live market indices
AB
NSE · Equity shares · Biotechnology & Drugs

Abbott India ABBOTINDIA

NSE:INR 27,900Recorded price
BSE:INR 27,964.5Recorded price
Not available · Not available
Advanced chart
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

Previous closeData unavailable
Day rangeINR 27,747.6 — INR 28,162.45
52-week rangeINR 25,049.28 — INR 34,063.99
VolumeNot available
Market cap59,216.35
P/E35.32
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)6,929.05
Net Income (INR Cr)1,552.02
Rev Growth (5 Year %)9.96
EPS Growth (5 Year %)17.58
P/E Ratio35.32
Book Value2,244.97
EPS735.34
Price/BV12.43Computed

Research path: Interpret Abbott India's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.

AI and Advanced

AI analysis and Advanced tools for ABBOTINDIA

Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.

AI analysisReview the complete evidence-led AI research workflow.Generate reportCreate a versioned report with entitlement and credit checks.Open AI ChatContinue a grounded conversation with the instrument in context.Advanced modulesOpen role- and entitlement-controlled portfolio and trading tools.
Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Open full workspace
Interactive price chartInteractive chart loads when this section is visible.
Auditable calculations

Daily technical summary

Calculated from validated daily candles. Descriptive research only.

Calculating technicals…
Intelligence: activity, structure and reported deals

Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.

Company derivatives · NSE

ABBOTINDIA futures & options

Expiry structure, futures, option chains and contract research.

Snapshot · timestamp unavailable
No observations

No matching contracts have verified observations for this filter.

DIRECTION · ACTIVITY · DISCLOSURES

ABBOTINDIA Intelligence

Stored price, volume, causal structure and reported deals for this stock.

Market map
Checking research access…

Volume and pressure are activity estimates, not net money inflow. Futures and options retain their separate observations above.

Company reporting

Financial statements

IND AS · INR crore

Metric202620252024
Total Liabilities Shareholders' Equity6,501.935,917.315,193.49
Accumulated Depreciation Total-177.92-163.74-146.25
Cash Equivalents369480.4177.99
Other Liabilities Total117.51119.22115.12
Accrued Expenses128.5351.0647.76
Common Stock Total21.2521.2521.25
Other Equity Total-9.46-8.61-3.19
Other Current Assets Total26.9744.6717.64
Prepaid Expenses9.278.799.01
Total Assets6,501.935,917.315,193.49
Current Portof LT Debt/Capital Leases38.3338.9246.47
Cash73.3380.19113.75
Total Equity4,774.194,233.153,698.89
Long Term Investments2,178719.71,618.42
Retained Earnings(Accumulated Deficit)4,735.884,191.633,640.67
Total Common Shares Outstanding2.122.122.12
Property/Plant/Equipment Total-Gross510.97511.34374.64
Tangible Book Valueper Share Common Eq2,244.971,989.11,737.58
Total Liabilities1,727.741,684.161,494.6
Total Debt171.99196.6783.23
Short Term Investments1,7902,554.311,827.97
Cashand Short Term Investments2,232.333,114.92,119.71
Total Receivables Net554.86714.71479.9
Notes Payable/Short Term Debt000
Accounts Receivable-Trade Net385.21612.55346.15
Property/Plant/Equipment Total-Net333.05347.6228.39
Total Current Liabilities1,476.571,407.191,342.72
Total Inventory947.26882.04619.58
ESOP Debt Guarantee26.5228.8840.16
Accounts Payable1,106.931,057.861,002.69
Other Currentliabilities Total202.78259.35245.8
Total Long Term Debt133.66157.7536.76
Intangibles Net3.786.466.66
Other Long Term Assets Total43.5214.9615.85
Note Receivable-Long Term172.8963.4878.33
Total Current Assets3,770.694,765.113,245.84
Capital Lease Obligations133.66157.7536.76
Fundamentals

Valuation and ratios

Valuation

PEG Ratio2.14

Price to Sale Ratio8.55

Growth

Debt 5Yr CAGR %2.42

Margins

Operating Margin 12m26.21

Operating Margin 5y Avg23.76

Net Profit Margin 12m22.4

Net Profit Margin 5y20.08

Yield

Dividend Yield %1.89

Risk and consensus

Source-qualified signals

Risk metrics

Overall RiskModerate risk

Board Risk21.33

Analyst consensus

ConsensusStrong Buy

Consensus score1.57

Analyst opinions7

Strong Sell count0

Sell count0

Hold count1

Buy count2

Strong Buy count4

Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.
Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

CompanyPriceMarket capP/EResearch
Sun Pharmaceutical IndustriesINR 1,9444.66 L38.4—
Divi's LaboratoriesINR 8,291.552.20 L73.32—
Torrent PharmaceuticalsINR 4,9651.89 L72.73—
CiplaINR 1,4751.19 L27.57—
Zydus LifesciencesINR 1,106.251.10 L21.19—
Shareholding

Ownership

Promoter
74.99%
FII
0.38%
MF
7.44%
Other
17.19%
Corporate actions

Events

  1. annual General MeetingAGM
  2. annual General MeetingAGM
  3. board MeetingsQuarterly Results
  4. dividendRs.525.0000 per share(5250%)Final Dividend
  5. dividendRs.131.0000 per share(1310%)Special Dividend
  6. annual General MeetingPOM
  7. board MeetingsAudited Results & Final Dividend
  8. annual General MeetingPOM
  9. board MeetingsQuarterly Results
  10. board MeetingsQuarterly Results
  11. annual General MeetingAGM
  12. board MeetingsQuarterly Results
  13. dividendRs.475.0000 per share(4750%)Final Dividend
  14. board MeetingsAudited Results & Final Dividend
  15. board MeetingsQuarterly Results
  16. board MeetingsQuarterly Results
  17. annual General MeetingAGM
  18. board MeetingsQuarterly Results
  19. dividendRs.410.0000 per share(4100%)Final Dividend
  20. board MeetingsAudited Results & Final Dividend
Rusaka Markets Community

Discussion and sentiment for Abbott India

Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.

Rusaka Markets Community

Community discussion loads as you approach this section.

Company profile

Business information

What the company does

Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.

Company facts

Industry
Biotechnology & Drugs
Sector
Biotechnology & Drugs
NSE Code
ABBOTINDIA
BSE Code
500488
Questions

Stock FAQ

What is the symbol and ISIN of Abbott India?

Abbott India has the symbol ABBOTINDIA and ISIN - INE358A01014.

What is the latest recorded price of Abbott India?

The latest available recorded price of Abbott India is INR 27,900.00 as of 2026-08-06T20:47:27.871Z. This is a source-stamped snapshot, not a live quote.

What are the year high and year low of Abbott India?

Year high: INR 34,063.99. Year low: INR 25,049.28.

What is the market capitalization of Abbott India?

Market capitalization: INR 59,216.35 crore.

What is the P/E ratio of Abbott India?

P/E ratio: 35.32.

What is the dividend yield of Abbott India?

Dividend yield: 1.89%.

How is the financial performance of Abbott India based on revenue, net income, and EPS?

Revenue: INR 6,929.05 crore. Net income: INR 1,552.02 crore. EPS: INR 736.64.

What is the book value of Abbott India?

Book value: INR 2,244.97.

What are the price-to-book and price-to-sales ratios of Abbott India?

Price-to-book ratio: 12.43. Price-to-sales ratio: 8.55.

Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.